标题
Immune checkpoints and rheumatic diseases: what can cancer immunotherapy teach us?
作者
关键词
-
出版物
Nature Reviews Rheumatology
Volume 12, Issue 10, Pages 593-604
出版商
Springer Nature
发表日期
2016-08-19
DOI
10.1038/nrrheum.2016.131
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The Basis of Oncoimmunology
- (2016) A. Karolina Palucka et al. CELL
- Immunoglobulin isotype knowledge and application to Fc engineering
- (2016) Randall J Brezski et al. CURRENT OPINION IN IMMUNOLOGY
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- TIGIT overexpression diminishes the function of CD4 T cells and ameliorates the severity of rheumatoid arthritis in mouse models
- (2016) Weigong Zhao et al. EXPERIMENTAL CELL RESEARCH
- Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study
- (2016) Scott Antonia et al. LANCET ONCOLOGY
- Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease
- (2016) Christian Lood et al. NATURE MEDICINE
- The "cancer immunogram"
- (2016) C. U. Blank et al. SCIENCE
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Autoimmune Arthropathy and Uveitis as Complications of Programmed Death 1 Inhibitor Treatment
- (2016) Guillermo de Velasco et al. Arthritis & Rheumatology
- Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders
- (2016) Douglas B. Johnson et al. JAMA Oncology
- A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)
- (2015) Kenneth C Kalunian et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanisms
- (2015) A. Pellerin et al. EMBO Molecular Medicine
- Upholding the T cell immune-regulatory function of CD31 inhibits the formation of T/B immunological synapses in vitro and attenuates the development of experimental autoimmune arthritis in vivo
- (2015) Marc Clement et al. JOURNAL OF AUTOIMMUNITY
- Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
- (2015) Dirk Schadendorf et al. JOURNAL OF CLINICAL ONCOLOGY
- The IL-23–IL-17 axis in inflammatory arthritis
- (2015) Erik Lubberts Nature Reviews Rheumatology
- Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
- (2015) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients
- (2015) Emanuela Romano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-α, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients
- (2015) Vanessa Fleischer et al. ARTHRITIS RESEARCH & THERAPY
- Soluble PD-1 aggravates progression of collagen-induced arthritis through Th1 and Th17 pathways
- (2015) Cuiping Liu et al. ARTHRITIS RESEARCH & THERAPY
- Rapid complete response of metastatic melanoma in a patient undergoing ipilimumab immunotherapy in the setting of active ulcerative colitis
- (2015) A Doran Bostwick et al. Journal for ImmunoTherapy of Cancer
- Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma
- (2015) Ahmad A. Tarhini et al. Journal for ImmunoTherapy of Cancer
- Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lprmice
- (2014) Jason S Knight et al. ANNALS OF THE RHEUMATIC DISEASES
- Successful treatment with Ipilimumab and Interleukin-2 in two patients with metastatic melanoma and systemic autoimmune disease
- (2014) Magnus Pedersen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Soluble Leukocyte-Associated Ig-Like Receptor (LAIR)-2 Antagonizes the Collagen/LAIR-1 Inhibitory Immune Interaction
- (2014) R. J. Lebbink et al. JOURNAL OF IMMUNOLOGY
- PILRα Negatively Regulates Mouse Inflammatory Arthritis
- (2014) Yonglian Sun et al. JOURNAL OF IMMUNOLOGY
- Ipilimumab in patients with cancer and the management of dermatologic adverse events
- (2014) Mario E. Lacouture et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease
- (2014) Jennifer Müller et al. Nature Reviews Rheumatology
- Disruption of the immune-checkpoint VISTA gene imparts a proinflammatory phenotype with predisposition to the development of autoimmunity
- (2014) L. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aberrant CD200/CD200R1 expression and its potential role in Th17 cell differentiation, chemotaxis and osteoclastogenesis in rheumatoid arthritis
- (2014) Yan Ren et al. RHEUMATOLOGY
- Immune checkpoint receptors in regulating immune reactivity in rheumatic disease
- (2014) Sabrina Ceeraz et al. ARTHRITIS RESEARCH & THERAPY
- Ipilimumab in patients with melanoma and autoimmune disease
- (2014) Chrisann Kyi et al. Journal for ImmunoTherapy of Cancer
- Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study
- (2013) Daniel J Wallace et al. ANNALS OF THE RHEUMATIC DISEASES
- Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumab
- (2013) E. A. Rossi et al. BLOOD
- Organizing Pneumonia as a Side Effect of Ipilimumab Treatment of Melanoma
- (2013) Igor Z. Barjaktarevic et al. CHEST
- Do inhibitory immune receptors play a role in the etiology of autoimmune disease?
- (2013) Marloes J.M. Olde Nordkamp et al. CLINICAL IMMUNOLOGY
- An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations
- (2013) Omid Vafa et al. METHODS
- CD200R/CD200 Inhibits Osteoclastogenesis: New Mechanism of Osteoclast Control by Mesenchymal Stem Cells in Human
- (2013) Audrey Varin et al. PLoS One
- Ligation of Signal Inhibitory Receptor on Leukocytes-1 Suppresses the Release of Neutrophil Extracellular Traps in Systemic Lupus Erythematosus
- (2013) Kristof Van Avondt et al. PLoS One
- Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up
- (2013) Daniel J. Wallace et al. RHEUMATOLOGY
- Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006
- (2013) V. Strand et al. RHEUMATOLOGY
- Cancer Immunotherapy
- (2013) J. Couzin-Frankel SCIENCE
- SeXX matters in immunity
- (2013) J.G. Markle et al. TRENDS IN IMMUNOLOGY
- Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve-Month, Randomized, Double-Blind Study
- (2013) Richard Furie et al. Arthritis & Rheumatology
- CD22 ligation inhibits downstream B cell receptor signaling and Ca2+flux upon activation
- (2012) N. Sieger et al. ARTHRITIS AND RHEUMATISM
- CD200R signaling in tumor tolerance and inflammation: A tricky balance
- (2012) Tomasz P Rygiel et al. CURRENT OPINION IN IMMUNOLOGY
- Neutrophil infiltration during inflammation is regulated by PILRα via modulation of integrin activation
- (2012) Jing Wang et al. NATURE IMMUNOLOGY
- Disease Tolerance as a Defense Strategy
- (2012) R. Medzhitov et al. SCIENCE
- CD200 Receptor Controls Sex-Specific TLR7 Responses to Viral Infection
- (2012) Guruswamy Karnam et al. PLoS Pathogens
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- An update on an immune system that goes awry in systemic sclerosis
- (2011) L. van Bon et al. CURRENT OPINION IN RHEUMATOLOGY
- Vstm3 is a member of the CD28 family and an important modulator of T-cell function
- (2011) Steven D. Levin et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
- (2011) Li Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Antibody-Mediated Coengagement of FcγRIIb and B Cell Receptor Complex Suppresses Humoral Immunity in Systemic Lupus Erythematosus
- (2011) Holly M. Horton et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
- (2011) N. Joller et al. JOURNAL OF IMMUNOLOGY
- Systemic Lupus Erythematosus
- (2011) George C. Tsokos NEW ENGLAND JOURNAL OF MEDICINE
- Genome-Wide Association Analysis of Autoantibody Positivity in Type 1 Diabetes Cases
- (2011) Vincent Plagnol et al. PLoS Genetics
- The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: Results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial
- (2010) J. T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Abatacept in the treatment of patients with psoriatic arthritis: Results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial
- (2010) Philip Mease et al. ARTHRITIS AND RHEUMATISM
- Immune Inhibitory Ligand CD200 Induction by TLRs and NLRs Limits Macrophage Activation to Protect the Host from Meningococcal Septicemia
- (2010) Subhankar Mukhopadhyay et al. Cell Host & Microbe
- CD200R1 regulates the severity of arthritis but has minimal impact on the adaptive immune response
- (2010) E. Šimelyte et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Signal Inhibitory Receptor on Leukocytes-1 Is a Novel Functional Inhibitory Immune Receptor Expressed on Human Phagocytes
- (2010) T. A. M. Steevels et al. JOURNAL OF IMMUNOLOGY
- TCR Stimulation Drives Cleavage and Shedding of the ITIM Receptor CD31
- (2010) G. Fornasa et al. JOURNAL OF IMMUNOLOGY
- CD200R1 Agonist Attenuates Mechanisms of Chronic Disease in a Murine Model of Multiple Sclerosis
- (2010) Y. Liu et al. JOURNAL OF NEUROSCIENCE
- Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
- (2010) Eli A Stahl et al. NATURE GENETICS
- Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
- (2010) Andre Franke et al. NATURE GENETICS
- Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes
- (2009) Jeffrey C Barrett et al. NATURE GENETICS
- Scleroderma
- (2009) Armando Gabrielli et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD200-FC, a novel antiarthritic biologic agent that targets proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis
- (2008) Egle Šimelyte et al. ARTHRITIS AND RHEUMATISM
- Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis
- (2008) Martial Koenig et al. ARTHRITIS AND RHEUMATISM
- Systemic increase in type I interferon activity in Sjögren's syndrome: A putative role for plasmacytoid dendritic cells
- (2008) Manon E. Wildenberg et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future
- (2008) Marc Daëron et al. IMMUNOLOGICAL REVIEWS
- Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci
- (2008) Jason D Cooper et al. NATURE GENETICS
- The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
- (2008) Xin Yu et al. NATURE IMMUNOLOGY
- The inhibitory CD200R is differentially expressed on human and mouse T and B lymphocytes
- (2007) Eva S.K. Rijkers et al. MOLECULAR IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now